Filing Details
- Accession Number:
- 0000950170-24-008020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-26 17:10:05
- Reporting Period:
- 2024-01-24
- Accepted Time:
- 2024-01-26 17:10:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1589597 | Edward Troy Wilson | C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-24 | 6,945 | $4.80 | 7,504 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-01-24 | 6,945 | $20.23 | 559 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-01-24 | 84,107 | $6.15 | 84,666 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-01-24 | 84,107 | $20.23 | 559 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 300,000 | Indirect | by Lorax Charitable Remainder Unitrust |
| Common Stock | 279,194 | Indirect | by One Fish Two Fish Revocable Trust |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022.
Billionaire Hedge Funds
